Jack W. Callicutt
Chief Financial Officer at Galectin Therapeutics · 40 reported transactions in 1 company · latest trade Jan 6, 2026
Their trades
Sold | Jan 6, 2026 | Jan 6, 2026 close $3.45 → Oct 28, 2026 close $3.54. S&P 500 +11.6% over the same days. | ||
Sold | Jan 5, 2026 | Jan 5, 2026 close $3.88 → Oct 28, 2026 close $3.54. S&P 500 +12.3% over the same days. | ||
Sold | Jan 2, 2026 | Jan 2, 2026 close $4.05 → Oct 28, 2026 close $3.54. S&P 500 +13.1% over the same days. | ||
Sold | Nov 18, 2025 | Nov 18, 2025 close $6.19 → Oct 28, 2026 close $3.54. S&P 500 +17.0% over the same days. | ||
Sold | Nov 18, 2025 | Nov 18, 2025 close $6.19 → Oct 28, 2026 close $3.54. S&P 500 +17.0% over the same days. | ||
Sold | Nov 17, 2025 | Nov 17, 2025 close $6.00 → Oct 28, 2026 close $3.54. S&P 500 +16.0% over the same days. |
$74.7K
Jan 6, 2026 close $3.45 → Oct 28, 2026 close $3.54. S&P 500 +11.6% over the same days.
$100.3K
Jan 5, 2026 close $3.88 → Oct 28, 2026 close $3.54. S&P 500 +12.3% over the same days.
$58.4K
Jan 2, 2026 close $4.05 → Oct 28, 2026 close $3.54. S&P 500 +13.1% over the same days.
$113.3K
Nov 18, 2025 close $6.19 → Oct 28, 2026 close $3.54. S&P 500 +17.0% over the same days.
$174.9K
Nov 18, 2025 close $6.19 → Oct 28, 2026 close $3.54. S&P 500 +17.0% over the same days.
$14K
Nov 17, 2025 close $6.00 → Oct 28, 2026 close $3.54. S&P 500 +16.0% over the same days.